Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INTERFERON BETA-1A Cause Pulmonary hypertension? 75 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Pulmonary hypertension have been filed in association with INTERFERON BETA-1A (Avonex). This represents 0.1% of all adverse event reports for INTERFERON BETA-1A.

75
Reports of Pulmonary hypertension with INTERFERON BETA-1A
0.1%
of all INTERFERON BETA-1A reports
5
Deaths
35
Hospitalizations

How Dangerous Is Pulmonary hypertension From INTERFERON BETA-1A?

Of the 75 reports, 5 (6.7%) resulted in death, 35 (46.7%) required hospitalization, and 2 (2.7%) were considered life-threatening.

Is Pulmonary hypertension Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA-1A. However, 75 reports have been filed with the FAERS database.

What Other Side Effects Does INTERFERON BETA-1A Cause?

Multiple sclerosis relapse (5,931) Influenza like illness (4,475) Memory impairment (3,468) Multiple sclerosis (3,412) Fatigue (3,164) Fall (3,128) Gait disturbance (3,031) Death (2,766) Pain (2,692) Headache (2,533)

What Other Drugs Cause Pulmonary hypertension?

TREPROSTINIL (1,931) MACITENTAN (1,505) AMBRISENTAN (1,504) SELEXIPAG (681) EPOPROSTENOL (591) SILDENAFIL (517) BOSENTAN (504) TADALAFIL (428) RIOCIGUAT (411) ADALIMUMAB (287)

Which INTERFERON BETA-1A Alternatives Have Lower Pulmonary hypertension Risk?

INTERFERON BETA-1A vs INTERFERON BETA-1B INTERFERON BETA-1A vs INTERFERON GAMMA INTERFERON BETA-1A vs INTERFERON GAMMA-1B INTERFERON BETA-1A vs INVEGA INTERFERON BETA-1A vs INVEGA SUSTENNA

Related Pages

INTERFERON BETA-1A Full Profile All Pulmonary hypertension Reports All Drugs Causing Pulmonary hypertension INTERFERON BETA-1A Demographics